2 years ago
CABA
AnalystsSamantha SemenkowSamantha Semenkow's Stock Forecasts
AnalystsSamantha Semenkow
Sectors:
Analyst Ranking
Top 25%
#1288 out of 5184 analysts
Average Return
+6.11%
Win Rate
44%26 out of 59
Risk vs Reward
Poor
Good
Samantha Semenkow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | +233.59% | $27.09 | $90.37 | 2025-05-02 - 2026-01-23 | Strong Buy |
Bioage Labs IncBIOA | +210.91% | $6.05 | $18.81 | 2025-10-22 - 2026-01-23 | Strong Buy |
Bioage Labs IncBIOA | +144.92% | $7.68 | $18.81 | 2025-10-29 - 2026-01-23 | Strong Buy |
Morphic Holding IncMORF | +109.75% | $27.17 | $56.99 | 2023-12-08 - 2024-08-16 | Strong Buy |
Larimar Therapeutics IncLRMR | +103.34% | $3.29 | $6.69 | 2023-11-17 - 2024-11-15 | Strong Buy |
Samantha Semenkow Analyst Color
Get additional color on Samantha Semenkow's coverage of popular stocks
2 years ago
EDIT
2 years ago
LRMR
Samantha Semenkow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Argenx SeARGX | 8 | Strong Buy | $1,091.00 | +33.91% | Maintains | 16 days ago |
Amicus Therapeutics IncFOLD | 2 | Hold | $14.50 | +1.61% | Downgrades | a month ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $64.00 | +99.78% | Initiates Coverage On | a month ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $30.00 | +122.72% | Maintains | a month ago |
Structure Therapeutics IncGPCR | 2 | Strong Buy | $100.00 | +10.66% | Maintains | a month ago |
Nektar TherapeuticsNKTR | 1 | Strong Buy | $102.00 | +174.86% | Initiates Coverage On | 2 months ago |
Agios Pharmaceuticals IncAGIO | 1 | Strong Buy | $38.00 | +33.15% | Initiates Coverage On | 2 months ago |
Rhythm Pharmaceuticals IncRYTM | 1 | Strong Buy | $136.00 | +32.21% | Initiates Coverage On | 2 months ago |
Biohaven LtdBHVN | 2 | Strong Buy | $14.00 | +3.63% | Maintains | 2 months ago |
Prime Medicine IncPRME | 5 | Hold | $4.25 | -4.06% | Maintains | 2 months ago |
Roivant Sciences LtdROIV | 3 | Strong Buy | $26.00 | +15.15% | Maintains | 2 months ago |
Catalyst Pharmaceuticals IncCPRX | 3 | Strong Buy | $33.00 | +39.95% | Maintains | 3 months ago |
Bioage Labs IncBIOA | 5 | Strong Buy | $15.00 | -20.26% | Maintains | 3 months ago |
Moonlake ImmunotherapeuticsMLTX | 3 | Strong Sell | $5.00 | -68.47% | Downgrades | 3 months ago |
Cabaletta Bio IncCABA | 4 | Strong Buy | $10.00 | +214.47% | Maintains | 5 months ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $4.00 | +132.56% | Maintains | 8 months ago |
Acelyrin IncSLRN | 2 | Hold | $3.00 | N/A | Maintains | a year ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Sana Biotechnology IncSANA | 2 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Sensei Biotherapeutics IncSNSE | 2 | Strong Buy | $80.00 | N/A | Reinstates | 2 years ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $14.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 4 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 2 years ago |
Immunovant IncIMVT | 3 | Strong Buy | $50.00 | N/A | Maintains | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $56.00 | N/A | Maintains | 2 years ago |
9 Meters Biopharma IncNMTRQ | 3 | Hold | $0.75 | N/A | Maintains | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.